Valmark Advisers, Inc. Novartis Ag Transaction History

Valmark Advisers, Inc.

$6.38 Billion
Q4 2024

A detailed history of Valmark Advisers, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Valmark Advisers, Inc. holds 8,806 shares of NVS stock, worth $940,921. This represents 0.01% of its overall portfolio holdings.

Number of Shares

8,806

Previous 8,359 5.35%

Holding current value

$940,921

Previous $961,000 10.93%

% of portfolio

0.01%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	BUY	$96.78 - $117.18 $43,260 - $52,379	447 Added 5.35%	8,806 $856,000
Q3 2024 Oct 25, 2024	SELL	$106.13 - $120.89 $7,110 - $8,099	-67 Reduced 0.8%	8,359 $961,000
Q2 2024 Jul 31, 2024	BUY	$92.57 - $107.37 $12,404 - $14,387	134 Added 1.62%	8,426 $897,000
Q1 2024 May 03, 2024	BUY	$95.27 - $108.47 $4,572 - $5,206	48 Added 0.58%	8,292 $802,000
Q4 2023 Feb 02, 2024	SELL	$92.27 - $101.54 $92 - $101	-1 Reduced 0.01%	8,244 $832,000
Q3 2023 Nov 07, 2023	BUY	$94.73 - $105.13 $79,762 - $88,519	842 Added 11.37%	8,245 $839,000
Q2 2023 Aug 02, 2023	SELL	$92.52 - $104.91 $18,689 - $21,191	-202 Reduced 2.66%	7,403 $747,000
Q1 2023 May 01, 2023	BUY	$80.03 - $92.81 $14,005 - $16,241	175 Added 2.36%	7,605 $699,000
Q4 2022 Feb 06, 2023	SELL	$75.55 - $92.52 $1,208 - $1,480	-16 Reduced 0.21%	7,430 $674,000
Q3 2022 Nov 02, 2022	BUY	$74.61 - $87.26 $9,475 - $11,082	127 Added 1.74%	7,446 $566,000
Q2 2022 Aug 01, 2022	SELL	$80.52 - $93.75 $8,696 - $10,125	-108 Reduced 1.45%	7,319 $619,000
Q4 2021 Feb 02, 2022	SELL	$79.7 - $88.13 $38,973 - $43,095	-489 Reduced 6.18%	7,427 $650,000
Q3 2021 Nov 09, 2021	SELL	$81.78 - $95.14 $26,823 - $31,205	-328 Reduced 3.98%	7,916 $647,000
Q2 2021 Aug 06, 2021	BUY	$85.24 - $94.15 $13,467 - $14,875	158 Added 1.95%	8,244 $752,000
Q1 2021 May 04, 2021	BUY	$83.5 - $98.47 $51,352 - $60,559	615 Added 8.23%	8,086 $691,000
Q4 2020 Feb 03, 2021	BUY	$78.07 - $94.43 $330,392 - $399,627	4,232 Added 130.66%	7,471 $705,000
Q3 2020 Nov 09, 2020	SELL	$82.14 - $91.0 $68,997 - $76,440	-840 Reduced 20.59%	3,239 $282,000
Q2 2020 Jul 31, 2020	BUY	$80.93 - $91.1 $330,113 - $371,596	4,079 New	4,079 $356,000

Others Institutions Holding NVS

# of Institutions

1,443

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.61M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $230B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Valmark Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Valmark Advisers, Inc. with notifications on news.

Account

Valmark Advisers, Inc. Novartis Ag Transaction History